Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mouth Neoplasms × Thalidomide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 106 Neoplasms, Plasma Cell 32 Neoplasms 13 Brain Neoplasms 12 Recurrence 11 Central Nervous System Neoplasms 11 Prostatic Neoplasms 10 Melanoma 10 Glioblastoma 10 Carcinoma, Hepatocellular 10 Leukemia 8 Gliosarcoma 8 Carcinoma, Non-Small-Cell Lung 8 Waldenstrom Macroglobulinemia 7 Leukemia, Lymphocytic, Chronic, B-Cell 7 Glioma 7 Carcinoma, Renal Cell 7 Sarcoma 6 Lung Neoplasms 6 Colorectal Neoplasms 6 Lymphoma, B-Cell, Marginal Zone 5 Lymphoma 5 Kidney Neoplasms 5 Immunoglobulin Light-chain Amyloidosis 5 Myeloproliferative Disorders 4 Myelodysplastic Syndromes 4 Lymphoma, Mantle-Cell 4 Colonic Neoplasms 4 Astrocytoma 4 Rectal Neoplasms 3

Interventions

Cisplatin 27 Magnetic Resonance Spectroscopy 20 pembrolizumab 16 Specimen Handling 16 Radiotherapy 16 Cetuximab 15 Biopsy 13 Radiotherapy, Intensity-Modulated 12 Paclitaxel 10 Fluorouracil 10 Carboplatin 10 Radiation 9 Platinum 8 1,2-diaminocyclohexaneplatinum II citrate 8 Surveys and Questionnaires 7 Surgical Procedures, Operative 7 Drug Therapy 7 X-Rays 6 Taxes 6 Standard of Care 6 Celecoxib 6 Sentinel Lymph Node Biopsy 5 Observation 5 Nivolumab 5 Metformin 4 Interviews as Topic 4 Immunohistochemistry 4 Fluorodeoxyglucose F18 4 Docetaxel 4 Chemoradiotherapy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00934739 2015-02-25

A Study of High-Risk Oral Cavity Cancer

National Health Research Institutes, Taiwan

Phase 2/3 Terminated

Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡